1. Home
  2. ZUMZ vs TRDA Comparison

ZUMZ vs TRDA Comparison

Compare ZUMZ & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$26.22

Market Cap

363.1M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$9.86

Market Cap

386.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
TRDA
Founded
1978
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.1M
386.8M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
ZUMZ
TRDA
Price
$26.22
$9.86
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$24.50
AVG Volume (30 Days)
175.5K
298.3K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$900,253,000.00
$61,520,000.00
Revenue This Year
$5.50
N/A
Revenue Next Year
$1.36
N/A
P/E Ratio
$809.88
N/A
Revenue Growth
1.64
N/A
52 Week Low
$11.31
$4.93
52 Week High
$26.76
$21.79

Technical Indicators

Market Signals
Indicator
ZUMZ
TRDA
Relative Strength Index (RSI) 74.75 69.98
Support Level $25.35 $8.17
Resistance Level $26.76 $10.75
Average True Range (ATR) 1.00 0.67
MACD 0.36 0.07
Stochastic Oscillator 89.78 73.52

Price Performance

Historical Comparison
ZUMZ
TRDA

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: